View Publication
Export The prevalence of primary Sjogren’s syndrome (pSS) is between 1:100 and 1:1000 and it is therefore the most common connective tissue disease. Nevertheless, it can be difficult to diagnose pSS as the symptoms are frequently unspecific and diagnostic markers are lacking in many patients. In addition, only few controlled therapeutic studies of pSS have been carried out so that the optimal management is not yet clear. Meanwhile, outcome parameters to monitor clinical improvement have been developed and a large number of therapeutic studies are currently being performed. This review article summarizes the current diagnostic and treatment options for pSS.
SEEK ID: https://ldh.drfz.imise.uni-leipzig.de/publications/79
DOI: 10.1007/s00393-019-0625-8
Projects: German National Database of the Regional Cooperative Arthritis Centres (...
Publication type: Journal
Journal: Z Rheumatol
Citation: Z Rheumatol 78(6):511-517
Date Published: 2019
URL: https://www.ncbi.nlm.nih.gov/pubmed/30937527
Registered Mode: imported from a bibtex file
SubmitterViews: 40
Created: 15th Jul 2025 at 08:48
TagsThis item has not yet been tagged.
AttributionsNone
Download
https://orcid.org/0000-0002-3372-2021